NeuroMetrix, Inc.
NeuroMetrix develops the Quell Fibromyalgia wearable neurostimulation device, the first FDA-authorized medical device for reducing fibromyalgia symptoms, and sells it direct-to-consumer globally with recurring revenue from proprietary consumable electrodes.
- Company typePrivate
- Founded1996
- HeadquartersWoburn, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What NeuroMetrix, Inc. does
NeuroMetrix, Inc. is a U.S.-based medical device company that develops and commercializes non-invasive neurotechnology for the diagnosis and treatment of pain and neurological disorders. The company's core product is the Quell® Fibromyalgia system, a thin, wearable neuromodulation device worn on the upper calf that delivers electrical stimulation to sensory nerves. Quell is powered by a proprietary custom-designed microchip that enables flexible, high-power nerve stimulation in a credit-card-sized form factor, uses onboard position and motion sensing to auto-adjust therapy, and pairs via Bluetooth low energy with iOS and Android companion apps for personalized therapy management, sleep tracking, and severity monitoring. Quell is the first and only FDA-authorized medical device specifically indicated to help reduce fibromyalgia symptoms and is covered by 27 issued U.S. utility patents.
NeuroMetrix operates a hybrid hardware-plus-consumable business model: it sells the Quell device hardware directly to consumers through its own e-commerce storefront and generates the majority of its revenue from recurring aftermarket sales of proprietary disposable electrodes that are required to operate the device. Distribution is direct-to-consumer under the Quell brand, with customer service support via phone and email, and the company claims a cumulative installed reach of more than 5 million users across its healthcare products worldwide.
The company is now a wholly-owned subsidiary of electroCore, Inc., having been absorbed into a larger neurotechnology platform. Headcount is reported at 11–50 employees and the corporate office is located at 200 Forge Way, Suite 205, Rockaway, New Jersey. No revenue figures, funding rounds, or material expansion activity are disclosed in the available source materials.
NeuroMetrix, Inc. firmographics
Firmographics- Name
- NeuroMetrix, Inc.
- Legal name
- NeuroMetrix, Inc.
- Website
- https://neurometrix.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NeuroMetrix develops the Quell Fibromyalgia wearable neurostimulation device, the first FDA-authorized medical device for reducing fibromyalgia symptoms, and sells it direct-to-consumer globally with recurring revenue from proprietary consumable electrodes.
- Ownership category
- akta.pro rank
NeuroMetrix, Inc. industry classification
Industry- Product category
- Wearable Neuromodulation Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)
- akta.pro secondary industry
- Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM)
Keywords
Where NeuroMetrix, Inc. is headquartered
LocationHeadquarters
- HQ city
- Woburn
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NeuroMetrix, Inc. business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales
Revenue model
- Device Sales: Sale of the Quell Fibromyalgia wearable medical device hardware.
- Consumable Aftermarket Sales: The majority of revenue is generated by aftermarket sales of proprietary consumables (disposable electrodes). This creates recurring revenue from the installed device base.
Distribution channels1 record
NeuroMetrix, Inc. product offering
Product offeringCore offering
NeuroMetrix develops, manufactures, and sells the Quell® Fibromyalgia wearable neuromodulator, an FDA-authorized, non-invasive medical device that delivers transcutaneous electrical nerve stimulation to the upper calf to reduce fibromyalgia symptoms. The product is sold directly to patients and pairs with a smartphone app for dose customization, with recurring revenue from replacement electrode consumables.
Product overview
NeuroMetrix offers a unified product ecosystem centered on the Quell® Fibromyalgia system, which combines a wearable neuromodulation hardware device with a companion mobile app and proprietary consumable electrodes. The company develops non-invasive medical devices for pain and neurological disorder diagnosis and treatment, with the majority of revenue generated by aftermarket consumable sales. Over 5 million people worldwide have benefited from NeuroMetrix products.
Differentiator
Problem solved
Functional benefit
Brands
- Quell® Fibromyalgia: Advanced, non-invasive, nerve stimulation device that is the first and only FDA authorized medical device that helps reduce the symptoms of fibromyalgia. It is a thin wearable medical device inserted into a soft band, placed on the upper calf, that comfortably stimulates sensory nerves.
Products and services
- Quell® Fibromyalgia An FDA-authorized, non-invasive wearable neuromodulator placed on the upper calf that delivers transcutaneous electrical nerve stimulation to reduce fibromyalgia pain and improve sleep. It is targeted at adult consumers diagnosed with fibromyalgia who want an at-home, drug-free therapy, and pairs with a smartphone app for dose personalization and therapy tracking.
- Quell Fibromyalgia App Companion mobile application that communicates with the Quell® Fibromyalgia device over Bluetooth Low Energy to start/stop therapy, customize dose, track sleep, and reorder replacement electrodes. It is intended for the same fibromyalgia patient who uses the Quell device.
- Quell Replacement Electrodes Aftermarket disposable electrode consumables used with the Quell® Fibromyalgia wearable neuromodulator, purchased on a recurring basis by existing Quell users to keep the device functional.
Quantifiable outcome
- Majority of participants reported improvement in pain with regular use in 60-day home use test among 88 Quell users
Companies that use NeuroMetrix, Inc.
Customer profileSegments1 record
Ideal customer profiles1 record
NeuroMetrix, Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
NeuroMetrix, Inc. partnerships and signals
Strategic signalScale indicators1 record
Recent moves2 records
Expansion highlights4 records
NeuroMetrix, Inc. competitors and assessment
Company assessmentDirect peers
- Cala Health: Cala Health markets Cala Trio, a wearable transcutaneous peripheral nerve stimulation device for essential tremor; it is the closest direct comparable to NeuroMetrix's Quell as a prescription-grade wearable TENS-style neurostimulator sold to chronic-condition patients.
- DyAnsys: DyAnsys produces wearable neurostimulators (e.g., DrugRelief, Primary Relief) for pain and opioid-sparing applications; a direct peer as a small wearable-electrical-neurostimulation device company targeting chronic pain.
- iReliev (ExcelHealth): iReliev markets a range of OTC TENS/EMS combination units for pain relief and muscle recovery; comparable as a DTC-focused consumer TENS competitor with overlapping electrode-based recurring consumable economics.
- SPR Therapeutics: SPR Therapeutics commercializes peripheral nerve stimulation systems for chronic and acute pain; comparable to NeuroMetrix in the percutaneous/wearable nerve stimulation category for chronic pain management, with overlapping call points in pain specialists.
- Omron Healthcare: Omron sells consumer TENS/EMS pain-relief devices (e.g., Avail, PocketPain Pro) direct-to-consumer; comparable as a mass-market consumer-electronics TENS competitor to Quell in the same purchase channel.
Broad incumbents
- Inspire Medical Systems: Inspire is an implantable neurostimulation company for obstructive sleep apnea; comparable as a neuromodulation pure-play with FDA-authorized technology, a chronic-condition patient focus, and recurring implant/replacement economics.
- Axonics, Inc. Axonics develops implantable sacral and pudendal neuromodulation systems for incontinence; comparable as a neuromodulation device company focused on chronic-condition patients with an FDA-cleared, recurring-revenue consumables model (rechargeable IPG).
- Nevro Corp. Nevro markets the Senza spinal cord stimulation system for chronic pain; comparable as an established neuromodulation device company addressing chronic neuropathic pain with FDA-cleared technology and recurring implant revenue.
- Medtronic plc: Medtronic operates one of the broadest neuromodulation portfolios (spinal cord, deep brain, sacral, peripheral nerve stimulation); comparable as a broad incumbent in the same medical-device neuromodulation category where Quell competes.
- electroCore, Inc. NeuroMetrix's parent company and a developer of non-invasive vagus nerve stimulation (gammaCore) for migraine and other conditions; directly comparable as a non-invasive neuromodulation commercial-stage company, though with a different nerve target and indication focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
NeuroMetrix, Inc. social profiles
Digital presenceNeuroMetrix, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeuroMetrix, Inc. leadership team
Management profileNumber of profiles
NeuroMetrix, Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeuroMetrix, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeuroMetrix, Inc.
What does NeuroMetrix, Inc. do?
NeuroMetrix develops, manufactures, and sells the Quell® Fibromyalgia wearable neuromodulator, an FDA-authorized, non-invasive medical device that delivers transcutaneous electrical nerve stimulation to the upper calf to reduce fibromyalgia symptoms. The product is sold directly to patients and pairs with a smartphone app for dose customization, with recurring revenue from replacement electrode consumables.
Is NeuroMetrix, Inc. a public or private company?
NeuroMetrix, Inc. is a private company. It is classified as corporate owned and is currently operating.
When was NeuroMetrix, Inc. founded?
NeuroMetrix, Inc. was founded in 1996. It employs 11 to 50 people.
Where is NeuroMetrix, Inc. based?
NeuroMetrix, Inc. is headquartered in Woburn, United States, in the North America region.
How does NeuroMetrix, Inc. make money?
Two revenue lines are on record. Device Sales are the primary driver. The others are consumable Aftermarket Sales.
Who are NeuroMetrix, Inc.'s main competitors?
Direct peers on record are Cala Health, DyAnsys, iReliev (ExcelHealth), SPR Therapeutics and Omron Healthcare. Broad incumbents are Inspire Medical Systems, Axonics, Inc., Nevro Corp., Medtronic plc and electroCore, Inc..
Does NeuroMetrix, Inc. have an API?
No public API is recorded for NeuroMetrix, Inc..
What industry is NeuroMetrix, Inc. in?
NeuroMetrix, Inc.'s product category is Wearable Neuromodulation Devices. Its primary akta.pro industry code is CRACAQAK, Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices), with a secondary code of HLAKAIAM, Pain Medicine (Interventional/Neuropathic Pain). Its NAICS code is 334510 and its SIC code is 3845.